Related Experiment Videos
Inactivation of viruses in therapeutic products derived from human plasma
G Mitra1, M B Dobkin, R E Louie
1Cutter Biological of Miles Inc., Berkeley, California 94701.
The American Journal of Medicine
|June 24, 1988
Abstract:
Alpha-1-proteinase inhibitor concentrates have been prepared from pooled human plasma for therapeutic applications. Pasteurization (60 degrees C, 10 hours) conditions have been defined to reduce risks of transmission of viral agents without significant loss of biologic activity of the purified product. Human clinical data collected to date support the model virus inactivation studies regarding viral safety.